[X] Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

[ ] Transition Report under Section 13 or 15(d) of the Securities Exchange Act of 1934.

Former name, former address and former fiscal year, if changed since last report.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes [X] No [ ]

Copies of the Company's SEC filings can be found on its website at www.independenceholding.com

						March 31,		December 31,						June 30,		December 31,
						2005		2004						2005		2004
						(unaudited)								(unaudited)
ASSETS:	ASSETS:								ASSETS:
									Investments:
	Investments:									Short-term investments			$	14,765	$	21,470
		Short-term investments			$	21,333	$	21,470		Securities purchased under agreements to resell				12,437		93,544
		Securities purchased under agreements to resell				56,437		93,544		Fixed maturities				684,640		546,384
		Fixed maturities				555,516		546,384		Equity securities				48,101		12,099
		Equity securities				23,174		12,099		Other investments				56,080		48,679
		Other investments				46,286		48,679
											Total investments			816,023		722,176
			Total investments			702,746		722,176
									Cash and cash equivalents					10,293		13,196
	Cash and cash equivalents					13,051		13,196	Due from securities brokers					29,715		4,795
	Due from securities brokers					16,746		4,795	Investment in American Independence Corp. ("AMIC")					33,255		30,626
	Investment in American Independence Corp. ("AMIC")					30,968		30,626	Deferred acquisition costs					56,358		37,386
	Deferred acquisition costs					43,007		37,386	Due and unpaid premiums					10,463		7,100
	Due and unpaid premiums					7,786		7,100	Due from reinsurers					116,484		121,987
	Due from reinsurers					119,992		121,987	Notes and other receivables					9,611		7,172
	Notes and other receivables					7,871		7,172	Goodwill					13,625		5,901
	Other assets					37,349		24,055	Other assets					25,466		18,154

		Total assets			$	979,516	$	968,493		Total assets			$	1,121,293	$	968,493

LIABILITIES AND STOCKHOLDERS' EQUITY:	LIABILITIES AND STOCKHOLDERS' EQUITY:								LIABILITIES AND STOCKHOLDERS' EQUITY:
LIABILITIES:	LIABILITIES:								LIABILITIES:
	Insurance reserves-health				$	158,556	$	166,087	Insurance reserves-health				$	149,032	$	166,087
	Insurance reserves-life and annuity					181,450		171,365	Insurance reserves-life and annuity					258,024		171,365
	Funds on deposit					314,725		308,465	Funds on deposit					359,909		308,465
	Unearned premiums					19,583		17,468	Unearned premiums					19,559		17,468
	Policy claims-life					6,701		6,590	Policy claims-life					6,473		6,590
	Policy claims-health					3,197		2,495	Policy claims-health					3,112		2,495
	Other policyholders' funds					9,455		8,859	Other policyholders' funds					11,919		8,859
	Due to securities brokers					23,112		14,760	Due to securities brokers					27,342		14,760
	Due to reinsurers					6,261		6,957	Due to reinsurers					6,933		6,957
	Accounts payable, accruals and other liabilities					19,056		25,948	Accounts payable, accruals and other liabilities					29,181		25,948
	Debt					12,500		12,500	Debt					12,500		12,500
	Junior subordinated debt securities					38,146		38,146	Junior subordinated debt securities					38,146		38,146

		Total liabilities				792,742		779,640		Total liabilities				922,130		779,640

STOCKHOLDERS' EQUITY:	STOCKHOLDERS' EQUITY:								STOCKHOLDERS' EQUITY:
	Preferred stock (none issued)					-		-	Preferred stock (none issued)					-		-
	Common stock $1.00 par value, 20,000,000 shares authorized;								Common stock $1.00 par value, 20,000,000 shares authorized;
			14,235,066 shares issued; 13,973,017 and 14,102,766			14,235		14,235			14,235,066 shares issued; 13,903,607 and 14,102,766
			shares outstanding, respectively								shares outstanding, respectively			14,235		14,235
	Paid-in capital					77,957		78,033	Paid-in capital					77,629		78,033
	Accumulated other comprehensive loss					(7,333)		(1,976)	Accumulated other comprehensive income (loss)					1,125		(1,976)
	Treasury stock, at cost; 262,049 and 132,300 shares,								Treasury stock, at cost; 331,459 and 132,300 shares,
				respectively		(4,774)		(2,376)				respectively		(6,033)		(2,376)
	Retained earnings					106,689		100,937	Retained earnings					112,207		100,937

		Total stockholders' equity				186,774		188,853		Total stockholders' equity				199,163		188,853

				Total liabilities and stockholders' equity	$	979,516	$	968,493				Total liabilities and stockholders' equity	$	1,121,293	$	968,493

The accompanying notes are an integral part of these consolidated financial statements.

												Three Months Ended				Six Months Ended
					Three Months Ended							June 30,				June 30,
					March 31,							2005		2004		2005		2004
					2005		2004

REVENUES:	REVENUES:							REVENUES:
								Health premiums earned			$	46,490	$	37,057	$	86,198	$	69,993
	Health premiums earned			$	39,708	$	32,936	Life and annuity premiums earned				9,291		8,382		19,011		15,783
	Life and annuity premiums earned				9,720		7,401	Net investment income				9,037		11,283		18,536		21,266
	Net investment income				9,499		9,983	Net realized and unrealized gains				836		425		1,084		1,320
	Net realized and unrealized gains				248		895	Equity income from AMIC				509		525		986		1,146
	Equity income from AMIC				477		621	MGU fee income				1,872		191		4,329		384
	Other income				6,021		596	Other income				947		250		4,511		653
												68,982		58,113		134,655		110,545
					65,673		52,432

EXPENSES:	EXPENSES:							EXPENSES:
	Insurance benefits, claims and reserves - health				25,757		20,957	Insurance benefits, claims and reserves -
	Insurance benefits, claims and reserves - life and									health		25,567		23,127		51,324		44,084
			annuity		10,904		8,974	Insurance benefits, claims and reserves -
	Amortization of deferred acquisition costs				2,651		1,379			life and annuity		10,220		8,750		21,124		17,724
	Interest expense on debt				845		560	Amortization of deferred acquisition costs				2,673		2,762		5,324		4,141
	Selling, general and administrative expenses				16,508		12,117	Interest expense on debt				865		502		1,710		1,062
								Selling, general and administrative expenses				21,028		14,381		37,536		26,498
					56,665		43,987
												60,353		49,522		117,018		93,509
	Income before income taxes				9,008		8,445
	Income tax expense				3,256		2,945	Income before income taxes				8,629		8,591		17,637		17,036
								Income tax expense				2,763		3,041		6,019		5,986
		Net income		$	5,752	$	5,500
									Net income		$	5,866	$	5,550	$	11,618	$	11,050

Basic income per common share	Basic income per common share			$	.41	$	.39	Basic income per common share			$	.42	$	.40	$	.83	$	.79

Weighted average shares outstanding	Weighted average shares outstanding				14,009		13,927	Weighted average shares outstanding				13,916		13,997		13,962		13,962

Diluted income per common share	Diluted income per common share			$	.40	$	.38	Diluted income per common share			$	.41	$	.39	$	.82	$	.77

Weighted average diluted shares outstanding	Weighted average diluted shares outstanding				14,332		14,341	Weighted average diluted shares outstanding				14,200		14,340		14,255		14,281

The accompanying notes are an integral part of these consolidated financial statements.

						Three Months Ended								Six Months Ended
						March 31,								June 30,
						2005		2004						2005		2004

CASH FLOWS FROM OPERATING ACTIVITIES:	CASH FLOWS FROM OPERATING ACTIVITIES:								CASH FLOWS FROM OPERATING ACTIVITIES:
	Net income				$	5,752	$	5,500	Net income				$	11,618	$	11,050
	Adjustments to reconcile net income to net cash from								Adjustments to reconcile net income to net cash from
			operating activities:								operating activities:
			Amortization of deferred acquisition costs			2,651		1,379			Amortization of deferred acquisition costs			5,324		4,141
			Net realized and unrealized gains			(248)		(895)			Net realized and unrealized gains			(1,084)		(1,320)
			Equity income from AMIC			(477)		(621)			Equity income from AMIC			(986)		(1,146)
			Depreciation and amortization			378		201			Depreciation and amortization			764		397
			Deferred tax expense			2,261		6			Deferred tax expense			4,015		1,329
			Other			(554)		47			Other			(864)		62
Changes in assets and liabilities:	Changes in assets and liabilities:								Changes in assets and liabilities:
			Net sales of trading securities			201		122			Net sales of trading securities			329		327
			Change in insurance liabilities			3,692		2,152			Change in insurance liabilities			(5,899)		(3,633)
			Additions to deferred acquisition costs			(6,565)		(1,967)			Additions to deferred acquisition costs			(11,085)		(5,822)
			Change in net amounts due from and to reinsurers			1,299		4,543			Change in net amounts due from and to reinsurers			9,323		5,638
			Change in income tax liability			(504)		1,449			Change in income tax liability			(502)		474
			Change in due and unpaid premiums			(685)		351			Change in due and unpaid premiums			(1,205)		364
			Other			(7,925)		(3,811)			Other			(5,778)		(2,344)

				Net cash from operating activities		(724)		8,456				Net cash from operating activities		3,970		9,517

CASH FLOWS FROM INVESTING ACTIVITIES:	CASH FLOWS FROM INVESTING ACTIVITIES:								CASH FLOWS FROM INVESTING ACTIVITIES:
			Change in net amount due from and to securities brokers			(3,598)		29,917			Change in net amount due from and to securities brokers			(12,338)		11,015
			Net (purchase) sale of short-term investments			36		(123)			Net proceeds of (payments for) short-term investments			6,718		(832)
			Net sales of securities under resale and repurchase agreements			37,107		11,498			Net sales of securities under resale and repurchase agreements			81,107		13,363
			Sales of equity securities			3,229		8,366			Sales of equity securities			4,675		10,193
			Purchases of equity securities			(14,400)		(4,716)			Purchases of equity securities			(40,993)		(6,853)
			Sales of fixed maturities			143,918		399,065			Sales of fixed maturities			425,229		620,424
			Maturities of fixed maturities			3,915		-			Maturities of fixed maturities			615		4,000
			Purchases of fixed maturities			(166,984)		(518,784)			Purchases of fixed maturities			(557,405)		(723,249)
			Proceeds of sales of other investments			4,214		1,805			Proceeds of sales of other investments			5,447		1,873
			Additional investments in other investments, net of distributions			(976)		(2,424)			Additional investments in other investments, net of distributions			(1,274)		(2,276)
			Purchase of subsidiary			(10,200)		-			Cash received in purchases of policy blocks			89,283		25,785
			Investment in AMIC			(69)		-			Purchase of subsidiary			(10,200)		-
			Change in notes and other receivables			(1,927)		5,110			Investment in AMIC			(2,215)		(1,464)
			Other			586		(1,137)			Change in notes and other receivables			(1,816)		5,434
											Other			(1,549)		(2,591)
				Net cash from investing activities		(5,149)		(71,423)
												Net cash from investing activities		(14,716)		(45,178)

CASH FLOWS FROM FINANCING ACTIVITIES:	CASH FLOWS FROM FINANCING ACTIVITIES:								CASH FLOWS FROM FINANCING ACTIVITIES:
		Repurchase of common stock				(2,656)		-		Repurchases of common stock				(4,744)		(3,579)
		Exercise of common stock options				92		149		Exercises of common stock options				350		1,938
		Proceeds of investment-type insurance contracts				8,645		5,255		Proceeds of investment-type insurance contracts				12,590		9,051
		Dividends paid				(353)		(386)		Dividends paid				(353)		(737)

				Net cash from financing activities		5,728		5,018				Net cash from financing activities		7,843		6,673

Decrease in cash and cash equivalents	Decrease in cash and cash equivalents					(145)		(57,949)	Decrease in cash and cash equivalents					(2,903)		(28,988)
Cash and cash equivalents, beginning of year	Cash and cash equivalents, beginning of year					13,196		60,547	Cash and cash equivalents, beginning of year					13,196		60,547

Cash and cash equivalents, end of period	Cash and cash equivalents, end of period				$	13,051	$	2,598	Cash and cash equivalents, end of period				$	10,293	$	31,559

The accompanying notes are an integral part of these consolidated financial statements.

Independence Holding Company ("IHC") is a holding company principally engaged in the life and health insurance business through its wholly-owned subsidiaries, Standard Security ~~Life~~ Insurance Company of New York ("Standard ~~Security Life"~~Security") and Madison ~~National~~ Life Insurance Company, Inc. ("Madison Life") and their subsidiaries (collectively, the "Insurance Group"), and ~~at March 31, 2005,~~ a ~~40%~~42% equity interest in the common stock of American Independence Corp. ("AMIC"). at June 30, 2005. IHC and its subsidiaries (including the Insurance Group) are collectively referred to as the "Company."

Geneve Corporation, a diversified financial holding company, and its affiliated entities ~~(collectively, "Geneve")~~ held ~~58.4%~~58.7% of IHC's outstanding common stock at ~~March 31,~~June 30, 2005.

The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles and include the accounts of IHC and its consolidated subsidiaries. All significant intercompany transactions have been eliminated in consolidation. The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect: (i) the reported amounts of assets and liabilities; (ii) the disclosure of contingent assets and liabilities at the date of the financial statements; and (iii) the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. IHC's annual report on Form 10-K as filed with the Securities and Exchange Commission should be read in conjunction with the accompanying consolidated financial statements.

In the opinion of management, all adjustments (consisting only of normal recurring accruals) that are necessary for a fair presentation of the consolidated financial position and results of operations for the interim periods have been included. The consolidated results of operations for the three months and six months ended ~~March 31,~~June 30, 2005 are not necessarily indicative of the results to be anticipated for the entire year.

On June 8, 2004, IHC declared a special 80% stock dividend, payable to shareholders of record on June 18, 2004 with a distribution date of July 2, 2004. The stock distribution was accounted for as a stock split effected in the form of a dividend. All share and per share data for the three months ended March 31, 2004 has been adjusted to reflect such dividend.

Certain amounts in prior years' ~~consolidated financial statements~~Consolidated Financial Statements and ~~Notes~~notes thereto have been reclassified to conform to the 2005 presentation.

The Company applies Accounting Principles Board ("APB") Opinion No. 25, "Accounting for Stock Issued to Employees", and related interpretations in accounting for its stock option plan. Since stock options under the plan are issued with an exercise price equal to the stock's fair value on date of grant, no compensation cost has been recognized in the Consolidated Statements of Operations. The Company follows the disclosure provisions of Statement of Financial Accounting Standards ("SFAS") No. 123, "Accounting for Stock-Based Compensation," as amended.

SFAS No. 123 establishes a fair value based method of accounting for stock-based compensation plans as an alternative to APB Opinion No. 25. Under SFAS No. 123, the compensation cost for options is measured at the grant date based on the value of the award, and such cost is recognized as an expense over the vesting period of the options. Compensation cost for stock appreciation rights ("SARs") is recognized over the service period of the award under both APB Opinion No. 25 and SFAS No. 123. Had the Company applied SFAS No. 123 in accounting for stock-based compensation awards, net income and net income per share for the three months and six months ended ~~March 31,~~June 30, 2005 and 2004 would have been as follows:

				Three Months Ended
				March 31,
									Three Months Ended				Six Months Ended
				2005		2004			June 30,				June 30,
				(In thousands, except per share data)					2005		2004		2005		2004

Net income, as reported	Net income, as reported		$	5,752	$	5,500	Net income, as reported	$	5,866	$	5,550	$	11,618	$	11,050
Add SAR expense included in reported
Add SAR expense included in reported net income,							Add SAR expense included in reported net income,
		net income, net of tax		-		106	net of tax		-		47		-		153
Deduct SAR and stock option expense
Deduct SAR and stock option expense under							Deduct SAR and stock option expense under
	under SFAS No. 123, net of tax			(175)		(360)	SFAS No. 123, net of tax		(165)		(125)		(340)		(485)
Pro forma net income	Pro forma net income		$	5,577	$	5,246	Pro forma net income	$	5,701	$	5,472	$	11,278	$	10,718

Basic income per common share:	Basic income per common share:						Basic income per common share:
	As reported		$	.41	$	.39	As reported	$	.42	$	.40	$	.83	$	.79
	Pro forma		$	.40	$	.38	Pro forma	$	.41	$	.39	$	.81	$	.77

Diluted income per common share:	Diluted income per common share:						Diluted income per common share:
	As reported		$	.40	$	.38	As reported	$	.41	$	.39	$	.82	$	.77
	Pro forma		$	.39	$	.37	Pro forma	$	.40	$	.38	$	.79	$	.75

~~A tax benefit~~Tax benefits of ~~$116,000~~$110,000 and ~~$169,000 was~~$51,000 were reflected in the pro forma expense under SFAS ~~No. 123~~No.123 for the three months ended ~~March 31,~~June 30, 2005 and 2004, respectively, and $226,000 and $220,000 for the six months ended June 30, 2005 and 2004, respectively.

As discussed in Note ~~10,~~11, the Company is required to adopt a fair-value-based method of accounting for stock options, beginning January 1, 2006, which will result in the recognition of compensation ~~expense.~~expense in the Consolidated Statements of Operations.

AMIC is an insurance holding company engaged in the insurance and reinsurance business. AMIC does business with the Insurance Group, including reinsurance treaties under which Standard ~~Life~~Security and Madison Life cede a portion of their medical stop-loss, New York Statutory Disability ("DBL"), small group major medical, and short-term medical business.

~~At March 31,~~ During the first and second quarter of 2005, the Company ~~owned 40%~~purchased 172,130 additional shares of ~~AMIC's outstanding~~AMIC common stock for $2,215,000, increasing its ownership in AMIC to 42% at June 30, 2005 compared to 40% at both December 31, 2004 and ~~accounted~~June 30, 2004.

The Company accounts for its investment ~~under~~in AMIC using the equity method of accounting. The carrying value of the Company's investment in AMIC, including goodwill of ~~$2,731,000,~~$3,361,000, was ~~$33,699,000~~$36,616,000 at ~~March 31,~~June 30, 2005, and its equity income was ~~$477,000~~$509,000 and $986,000 for the three and six months ended ~~March 31, 2005. At March 31, 2004, the Company owned 39% of AMIC's outstanding common stock.~~June 30, 2005, respectively. The Company's equity income was ~~$621,000~~$525,000 and $1,146,000 for the three months and six months ended ~~March 31, 2004. Subsequent to March 31, 2005, the Company increased its ownership in AMIC to 42%. In March and April 2005, the Company purchased 172,130 additional shares of AMIC for $2,215,000.~~June 30, 2004, respectively.

The Company ceded premiums to AMIC of ~~$13,059,000~~$14,504,000 and ~~$10,898,000~~$11,994,000 for the three months ended ~~March 31,~~June 30, 2005 and 2004, respectively, and $26,981,000 and $22,155,000 for the six months ended June 30, 2005 and 2004, respectively. Standard ~~Life~~Security earned ~~$61,000~~$63,000 and ~~$55,000~~$54,000 for the three months ended ~~March 31,~~June 30, 2005 and 2004, respectively, and $124,000 and $110,000 for the six months ended June 30, 2005 and 2004, respectively, from its service agreement with Independence American Insurance Company (a subsidiary of AMIC). The Company earned ~~$107,000~~$76,000 and ~~$77,000~~$82,000 for the three months ended ~~March 31,~~June 30, 2005 and 2004, respectively, and $182,000 and $159,000 for the six months ended June 30, 2005 and 2004, respectively, from its service agreement with AMIC.

Included in the diluted ~~earnings~~income per share ~~calculation~~calculations are 284,000 and 343,000 shares for the three months ended June 30, 2005 and 2004, respectively, ~~are 323,000~~ and ~~414,000~~293,000 and 319,000 shares for the six months ended June 30, 2005 and 2004, respectively, from the assumed exercise of options using the treasury stock method. Net income does not change as a result of the assumed dilution of options.

The following tables summarize, for all securities in an unrealized loss position at ~~March 31,~~June 30, 2005 and December 31, 2004, respectively, the aggregate fair value and gross unrealized loss by length of time those securities had continuously been in an unrealized loss position:

				Less than 12 Months				12 Months or Longer				Total						Less than 12 Months				12 Months or Longer				Total

				Fair		Unrealized		Fair		Unrealized		Fair		Unrealized				Fair		Unrealized		Fair		Unrealized		Fair		Unrealized
March 31, 2005				Value		Losses		Value		Losses		Value		Losses
June 30, 2005															June 30, 2005			Value		Losses		Value		Losses		Value		Losses
				(In thousands)														(In thousands)

Corporate securities	Corporate securities		$	138,049	$	6,654	$	25,306	$	2,289	$	163,355	$	8,943	Corporate securities		$	95,254	$	1,227	$	42,758	$	3,277	$	138,012	$	4,504
CMOs and ABS⁽¹⁾	CMOs and ABS⁽¹⁾			48,182		1,430		35,012		1,137		83,194	2,567		CMOs and ABS⁽¹⁾			33,142		541		42,560		1,169		75,702	1,710
US Government and	US Government and														US Government and
		agencies		36,450		1,440		-		-		36,450	1,440			agencies		9,440		21		21,986		88		31,426	109
Agency MBS⁽²⁾	Agency MBS⁽²⁾			31,293		364		2		-		31,295	364		Agency MBS⁽²⁾			18,053		59		2		-		18,055	59
GSE⁽³⁾	GSE⁽³⁾			60,215		1,229		8,229		106		68,444		1,335	GSE⁽³⁾			42,659		480		-		-		42,659		480
States and political	States and political														States and political
		subdivisions		47,550		1,443		-		-		47,550		1,443		subdivisions		13,849		111		-		-		13,849		111
Total fixed	Total fixed														Total fixed
	maturities			361,739		12,560		68,549		3,532		430,288	16,092		maturities			212,397		2,439		107,306		4,534		319,703	6,973
Common stock	Common stock			820		57		-		-		820	57		Common stock			540		84		97		10		637	94
Preferred stock	Preferred stock			10,713		192		-		-		10,713		192	Preferred stock			29,670		663		-		-		29,670		663
Total temporarily	Total temporarily														Total temporarily
	impaired securities		$	373,272	$	12,809	$	68,549	$	3,532	$	441,821	$	16,341	impaired securities		$	242,607	$	3,186	$	107,403	$	4,544	$	350,010	$	7,730

(1)Collateralized mortgage obligations ("CMOs") and asset-backed securities ("ABS").

Substantially all of the unrealized losses at ~~March 31,~~June 30, 2005 and December 31, 2004 relate to investment grade securities and are attributable to changes in market interest rates subsequent to purchase. There were no securities with unrealized losses that were individually significantdollar amounts at ~~March 31,~~June 30, 2005 and December 31, 2004. At ~~March 31,~~June 30, 2005 and December 31, 2004, a total of 7657 and 63 securities,respectively, were in a continuous unrealized loss position for less than 12 months and 1420 and 6 securities, respectively, had continuous unrealized losses for 12 months or longer. For fixed maturities, there are no securities past due or securities for which the Company currently believes it is not probable that it will collect all amounts due according to the contractual terms of the investment. Because the Company has the ability to ~~h old~~hold securities with unrealized losses until a market price recovery (which, for fixed maturities, may be until maturity) the Company did not consider these investments to be other-than-temporarily impaired at ~~March 31,~~June 30, 2005 and December 31, 2004.

The provision for income taxes shown in the ~~consolidated statements~~Consolidated Statements of ~~operations~~Operations was computed based on the Company's estimate of the effective tax ~~rates~~rate expected to be applicable for the current tax year.

The deferred income tax ~~benefit~~expense for the ~~three~~six months ended ~~March 31,~~June 30, 2005 allocated to stockholders' equity (principally for net unrealized ~~losses~~gains on investment securities) was ~~$2,998,000,~~$1,719,000, representing the change to a net deferred tax liability of $608,000 at June 30, 2005 versus a net deferred asset of ~~$4,109,000 at March 31, 2005 versus~~ $1,111,000 at December 31, 2004.

Cash payments for income taxes were ~~$1,501,000~~$2,511,000 and ~~$1,500,000~~$2,503,000 for the ~~three~~six months ended ~~March 31,~~June 30, 2005 and 2004, respectively. Cash payments for interest were ~~$933,000~~$1,729,000 and ~~$266,000~~$832,000 for the ~~three~~six months ended ~~March 31,~~June 30, 2005 and 2004, respectively.

The components of comprehensive income (loss) ~~income~~ include (i) net income or loss reported in the Consolidated Statements of Operations, and (ii) after-tax net unrealized gains and losses on securities available for sale (net of deferred acquisition costs) and a cash flow hedge which are reported directly in stockholders' equity. Comprehensive income (loss) ~~income~~ for the three months and six months ended ~~March 31,~~June 30, 2005 and 2004 is as follows:

										Three Months Ended				Six Months Ended
				Three Months Ended						June 30,				June 30,
				March 31,						2005		2004		2005		2004
				2005		2004				(In thousands)
				(In thousands)

Net income	Net income		$	5,752	$	5,500	Net income		$	5,866	$	5,550	$	11,618	$	11,050
	Unrealized (losses) gains:						Unrealized gains (losses):
		Securities available-for-sale		(5,466)		5,662		Securities available-for-sale		8,495		(14,143)		3,029		(9,192)
		Cash flow hedge		109		(201)		Cash flow hedge		(37)		(201)		72		309
Comprehensive income			$	395	$	10,961
Comprehensive income (loss)							Comprehensive income (loss)		$	14,324	$	(8,794)	$	14,719	$	2,167

On January 5, 2005, Strategic Health Associates Inc. ("SHA") acquired a 100% interest in Health Plan Administrators, Inc. ("HPA"), an administrator of short-term and temporary medical insurance products based in Rockford, Illinois and Tampa, Florida, for $12 million cash. IHC owns 80% of SHA with the remainder owned by Insurers Administrative Corporation ("IAC"), a leading individual and group health insurance administrator. Beginning in the first quarter of 2005, HPA offered short-term medical insurance in certain jurisdictions through Standard ~~Life.~~Security.

IHC acquired its 80% interest for $10,200,000 which includes $600,000 of direct costs associated with the acquisition. In addition, IHC loaned $1,800,000 to IAC in the form of a note receivable to fund IAC's portion of the acquisition. The loan has a 5% interest rate and is due in six equal annual installments commencing January 3, 2006. IHC recorded $7,071,000 of goodwill and $2,960,000 of other intangible assets in connection with the acquisition.

The Company has grown its life and annuity business primarily through acquisitions of blocks of business. Effective June 9, 2005, IHC acquired a block of life insurance policies with approximately $120 million in reserves, consisting of approximately $77 million of traditional life reserves, approximately $40 million of universal life and interest sensitive life reserves and approximately $3 million of other reserves. In the second quarter of 2004, IHC acquired a block of individual annuity policies through an assumption reinsurance agreement.

A summary of the amounts recorded by the Company as of the effective dates is as follows:

The Insurance Group principally engages in the life and health insurance business. ~~Interest expense, taxes, and general expenses associated with parent company activities are included in Corporate.~~ Certain allocations of items within segments have been reclassified in the 2004 information to reflect how management analyzes these segments currently. Information by business segment for the three months and six months ended ~~March 31,~~June 30, 2005 and 2004 is presented below:

		Three Months Ended
		March 31,					Three Months Ended					Six Months Ended
		2005			2004		June 30,					June 30,
		(In thousands)					2005		2004			2005		2004
							(In thousands)
Revenues:
Medical stop-loss	$	31,247	$	23,262		$	33,785	$	26,763	$	65,032		$	50,024
Strategic health	4,350		-				3,732		-			8,082		-
Group disability, life, annuities and DBL	11,950		11,437				12,674		12,118			24,625		23,555
Individual life, annuities and other	12,204		11,008				12,128		12,817			24,332		23,826
Credit life and disability	5,364		4,972				5,542		5,387			10,907		10,360
Corporate		310		858			285		603			593		1,460
	65,425		51,537				68,146		57,688			133,571		109,225
Net realized and unrealized gains		248		895			836		425			1,084		1,320
	$	65,673	$	52,432		$	68,982	$	58,113	$		134,655	$	110,545

Income (loss) before income taxes:
Medical stop-loss	$	9,286	$	5,607	$	6,810	$	4,958	$	16,096	$	10,564
Strategic health	(737)		-			(411)		-		(1,148)		-
Group disability, life, annuities and DBL	418		670			1,988		1,716		2,406		2,386
Individual life, annuities and other	951		2,055			1,132		2,140		2,083		4,196
Credit life and disability	232		(53)			111		945		343		893
Corporate		(545)		(169)		(972)		(1,091)		(1,517)		(1,261)
	9,605		8,110			8,658		8,668		18,263		16,778
Interest expense	(845)		(560)			(865)		(502)		(1,710)		(1,062)
Net realized and unrealized gains		248		895		836		425		1,084		1,320
	$	9,008	$	8,445	$	8,629	$	8,591	$	17,637	$	17,036

In May 2005, the Financial Accounting Standards Board (the "FASB") issued Statement of Financial Accounting Standards ("SFAS") No. 154, "Accounting Changes and Error Corrections," which replaces APB Opinion No. 20, "Accounting Changes," and SFAS No. 3, "Reporting Accounting Changes in Interim Financial Statements," and changes the requirements for the accounting for and reporting of a change in accounting principle. SFAS No. 154 applies to all voluntary changes in accounting principle and to changes required by an accounting pronouncement when the pronouncement does not include specific transition provisions. SFAS No. 154 requires retrospective application of changes in accounting principle to prior periods' financial statements unless it is impracticable to determine either the period-specific effects or the cumulative effect of the change. APB Opinion No. 20 previously required that most voluntary changes in accounting principle be recognized by including the cumulative effect of the change in net income for the period of the change in accounting principle. SFAS No. 154 carries forward without change the guidance contained in APB Opinion No. 20 for reporting the correction of an error in previously issued financial statements and a change in accounting estimate. SFAS No. 154 also carries forward the guidance in APB Opinion No. 20 requiring justification of a change in accounting principle on the basis of preferability. SFAS No. 154 is effective for accounting changes and corrections of errors made in fiscal years beginning after December 15, 2005, with early adoption permitted. The Company's adoption of SFAS No. 154 is not expected to affect its financial condition or results of operations.

On September 30, 2004, the ~~Financial Accounting Standards Board ("FASB")~~FASB issued Staff Position No. EITF Issue 03-1-1, "Effective Date of Paragraphs 10-20 of EITF Issue No. 03-1, The Meaning of Other-Than-Temporary Impairment and ~~Its~~its Application to Certain Investments," which ~~delays~~delayed the effective date ~~for~~of the measurement and recognition guidance contained in Emerging Issues Task Force ("EITF") Issue No. 03-1. As originally issued, EITF Issue No. 03-1 ~~provides~~provided guidance for evaluating whether an investment is other-than-temporarily impaired and was ~~originally~~ to be effective for other-than-temporary impairment evaluations made in reporting periods beginning after June 15, 2004 (July 1, 2004 for the Company). ~~The delay~~On June 29, 2005, the FASB directed its staff to issue Staff Position No. FAS 115-1, "The Meaning of Other-Than-Temporary-Impairment and Its Application to Certain Investments," which will supersede EITF Issue No. 03-1 and be effective for impairment analyses conducted in periods beginning after September 15, 2005. Staff Position No. F AS 115-1 will replace the ~~effective date for the measurement and recognition~~ guidance ~~contained~~ in EITF Issue No. 03-1 with references to existing authoritative literature concerning other-than-temporary impairments and clarify that an investor should recognize an impairment loss no later than when the impairment is deemed other-than-temporary, even if a decision to sell the investment has not be made. The Company does not ~~suspend the requirement to recognize other-than-temporary impairments as required by existing authoritative literature. Subsequent to~~expect that the issuance of Staff Position No. ~~EITF Issue 03-1-1, the FASB announced plans for~~FAS 115-1 will have a ~~full reconsideration~~material effect on its financial condition or results of existing authoritative literature concerning other-than-temporary impairment of securities. The outcome of this reconsideration and the impact, if any, on the Company's impairment recognition cannot be predicted at this time.

In December 2004, the FASB issued Statement of Financial Accounting Standards No. 123 (revised 2004) ("SFAS 123(R)"), "Share-Based Payment", which ~~supercedes~~supersedes SFAS No. 123, "Accounting for Stock-Based Compensation" ("SFAS 123") and APB Opinion No. 25, "Accounting for Stock Issued to Employees." SFAS 123(R) addresses the accounting for share-based payment transactions with employees and other third parties; eliminates the ability to account for share-basedcompensation transactions using APB 25; and requires that the compensation costs relating to such transactions be recognized in the statement of operations. In accordance with a rule issued by the Securities and Exchange Commission in April 2005, the compliance date for SFAS 123(R) is now the beginning of the first fiscal year beginning after June 15, 2005 and, therefore, the Company will adopt SFAS 123(R) on January 1, 2006, as required. SFAS 123(R) applies to all awards granted after the adoption date and to awards ~~modifie d, repurchased,~~modified, repur chased, or cancelled after that date. Additionally, beginning on the required adoption date, compensation expense will be recognized for the portion of outstanding awards for which the requisite service (vesting) has not yet been rendered, based on the grant-date fair value of those awards calculated under SFAS 123 for pro forma disclosures. The impact of adoption cannot be predicted at this time because it will depend, in part, on levels of share-based payments granted in the future. However, had the Company adopted SFAS 123(R) in prior periods, the impact of that standard would have approximated the impact of SFAS 123 as described in the pro forma disclosure included in Note 1(D).

On July 1, 2005, the Company, through its 80% owned subsidiary SHA, acquired a 75% interest in GroupLink, Inc. ("GroupLink"), an administrator of dental benefits based in Indianapolis, Indiana and its wholly-owned subsidiary, GroupLink Reinsurance Ltd., for $1.875 million in cash. A member of GroupLink's current management will continue to own the remaining 25% interest. Starting in the fourth quarter of 2005, it is anticipated that GroupLink will begin offering dental insurance in certain jurisdictions through Standard Security and Madison Life. GroupLink Reinsurance Ltd. solely reinsures dental business produced by GroupLink, Inc.

This Form 10-Q contains forward-looking statements that involve risks and uncertainties. The actual consolidated results of Independence Holding Company. ("IHC") and Subsidiaries (collectively referred to as the "Company") could differ significantly from those set forth herein. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in "Factors Affecting the Company's Operating Results" as set forth in the Company's annual report on Form 10-K for the fiscal year ended December 31, 2004, as filed with the Securities and Exchange Commission, and "Management's Discussion and Analysis of Financial Condition and Results of Operations" as well as those discussed elsewhere in this quarterly report. Statements contained herein that are not historical facts are forward-looking statements that are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Words such as "believes", "anticipates", "expe cts", "intends", "estimates", "likelihood", "unlikelihood", "assessment", and "foreseeable" and other similar expressions are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. A number of important factors could cause the Company's actual results for the year ending December 31, 2005, and beyond to differ materially from past results and those expressed or implied in any forward-looking statements made by the Company, or on its behalf. The Company undertakes no obligation to release publicly the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

The following discussion of the financial condition and results of operations of the Company should be read in conjunction with, and is qualified in its entirety by reference to, the Consolidated Financial Statements of the Company and the related Notes thereto appearing in our annual report on Form 10-K for the fiscal year ended December 31, 2004, as filed with the Securities and Exchange Commission and our Consolidated Financial Statements and related Notes thereto appearing elsewhere in this quarterly report.

~~The~~Since its inception the Company ishas been a life and health insurance holding ~~company principally~~company. In recent years, IHC has been primarily engaged in health insurance throughout the United States ~~and is~~as a leader in the medical stop-loss ~~industry nationally.~~market nationally and in niche health products, including short-term medical, high-deductible small group major medical and specialized long-term and short-term disability products. In addition, IHC has grown its life and annuity business primarily through acquisitions of blocks of business. The Company operates through (i) its ~~(i)~~ two insurance carriers (Standard Security ~~Life~~ and Madison Life), (ii) its 42% ownership interest in American Independence Corp. ("AMIC"), which owns medical stop-loss managing general underwriters ~~(MGUs)~~("MGUs") and Independence American Insurance Company; and (iii) its other MGUs, third party administrators, and marketing ~~affiliates..~~affiliates. Through its ownership of AMIC and other MGUs, IHC controls approximately ~~74%~~71% of the production ~~sources~~sour ces for its core ~~product~~ medical stop-loss business, while maintaining profitability through disciplined underwriting. Through its ownership of Health Plan Administrators Inc. ("HPA"), IHC controls the distribution of its short-term medical products. Through its ownership interest in CA Insurance Services ("CA Services") and its contractual relationship with Insurers Administrative Corporation ("IAC"), the Company controls the distribution of its group major medical products. Through its ownership, as of July 1, 2005, of GroupLink, Inc. ("GroupLink") the Company controls the distribution of its dental and vision products. IHC also writes group disability/DBL, group life and annuities, individual life and annuities, ~~and~~ credit life and ~~disability.~~disability and vision.These lines of business are targeted to niche markets. The majority of group life and disability business is focused in the upper Midwest school and public entity markets. The DBL business is written in New York State and ~~administered~~adm inistered through Standard ~~Security Life's~~Security's web-based back office. Individual life and annuities are written under a nation-wide program for volunteer emergency service, military and civilian government personnel. The credit life and disability business is marketed through a select group of producers. In addition, the Company's acquisition group assesses opportunities to acquire blocks of business based on the amount of reserves transferred and current interest rates.

While management considers a wide range of factors in its strategic planning and decision-making, underwriting profit is consistently emphasized as the primary goal in all decisions as to whether or not to increase our retention in a core line, expand into new products, acquire an entity or a block of business, or otherwise change our business model. Management's assessment of trends in healthcare and morbidity, with respect to medical stop-loss, major medical, short-term medical, dental, vision, disability and DBL; mortality rates with respect to life insurance; and changes in market conditions in general play a significant role in determining the rates charged, deductibles and attachment points quoted, and the percentage of business retained. Finally, management focuses on managing the costs of IHC's operations, which contributes to the Company's consistent profitability.

The following is a summary of key performance information and events for the three months and six months ended ~~March 31,~~June 30, 2005:

As disclosed in the Company's 2004 Form 10-K, Madison ~~National~~Life and Independence American entered into a reinsurance agreement to protect Independence American against certain losses from ~~Medical Stop-Loss~~medical stop-loss business occurring during the period from January 1, 2005 to December 31, 2005. Subsequent to the filing of the Company's Form 10-K, the parties mutually agreed to terminate the agreement as of its effective date of January 1, 2005. The parties made this determination after considering the development of Independence American's block of ~~Medical Stop-Loss~~medical stop-loss business to date.

The ~~Medical Stop-Loss~~medical stop-loss market is generally cyclical in nature. When a product experiences several consecutive years of underwriting profitability, it is not unusual for there to be more competitors entering that line which can increase pressure on pricing and create a "softer" market. The ~~Medical Stop-Loss~~medical stop-loss market began to "soften" in 2003, and less favorable conditions continued through 2004. Despite these market conditions, the Company produced profitable results in 2003 and 2004, and expects continued profitability in 2005. As a result of these market conditions, the rate IHC is able to charge for ~~Medical Stop-Loss~~medical stop-loss increased at a lesser rate in recent years, however, increases in medical trend have also been held in check to a greater extent and deductibles and attachment points have increased. This reduces IHC's overall risk exposure. The Company remains optimistic that it will continue to produce profitable results, however, its ability to grow the ~~Medical Stop-Loss~~medical stop-loss line in 2005 may be somewhat limited, although the Company intends to appoint new MGUs which would generate additional premiums. IHC's new lines of business (major medical, short-term medical, dental and vision) are less volatile than ~~Medical Stop-Loss.~~medical stop-loss. The Company remains optimistic that these lines will yield profitable results while producing significant growth.

Information pertaining to the Company's business segments is provided in Note 910 of Notes to Consolidated Financial Statements.

The accounting and reporting policies of the Company conform to U.S. generally accepted accounting principles ("GAAP"). The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. A summary of the Company's significant accounting policies is provided in Note 1 of the Notes to the Consolidated Financial Statements included in Item 8 of the Company's Annual Report on Form 10-K for the year ended December 31, 2004. Management has identified the accounting policies described below as those that, due to the judgments, estimates and assumptions inherent in those policies, are critical to an understanding of the Company's consolidated financial statements and management's discussion and analysis.

Traditional life insurance products consist principally of products with fixed and guaranteed premiums and benefits, primarily term and whole life insurance products. Premiums from these products are recognized as revenue when due.

Annuities and interest-sensitive life contracts, such as universal life and interest sensitive whole life, are contracts whose terms are not fixed and guaranteed. Premiums from these policies are reported as funds on deposit. Policy charges consist of fees assessed against the policyholder for cost of insurance (mortality risk), policy administration and early surrender. These revenues are recognized when assessed against the policyholder account balance.

Policies that do not subject the Company to significant risk arising from mortality or morbidity are considered investment contracts. Deposits received for such contracts are reported as other policyholder funds. Policy charges for investment contracts consist of fees assessed against the policyholder account for maintenance, administration and surrender of the policy prior to contractually specified dates, and are recognized when assessed against the policyholder account balance.

Premiums from short-duration medical insurance contracts are intended to cover expected claim costs resulting from insured events that occur during a fixed period of short duration. The Company has the ability to cancel the annual contract or to revise the premium rates at the beginning of each annual contract period to cover future insured events. Insurance premiums from annual health contracts are collected monthly and are recognized as revenue evenly as insurance protection is provided.

Premiums related to long-term and short-term disability contracts are recognized on a pro rata basis over the applicable contract term.

The Company maintains loss reserves to cover its estimated liability for unpaid losses and loss adjustment expenses, including legal, ~~and~~ other fees ~~as well as~~and a portion of the Company's general expenses, for reported and unreported claims incurred as of the end of each accounting period. These loss reserves are based on actuarial assumptions and are maintained at levels that are in accordance with GAAP. Many factors could affect these reserves, including economic and social conditions, inflation, healthcare costs, changes in doctrines of legal liability and damage awards in litigation. Therefore, the Company's reserves are necessarily based on estimates, assumptions and analysis of historical experience. The Company's results depend upon the variation between actual claims experience and the assumptions used in determining reserves and pricing products. Reserve assumptions and estimates require significant judgment and, therefore, are inherently uncertain. The Company cannot determine with precision the ultimate amounts that will be paid for actual claims or the timing of those payments.

Insurance reserves differ for short-duration and long-duration insurance policies and for annuities. Reserves are based on approved actuarial methods, but necessarily include assumptions about expenses, mortality, morbidity, lapse rates and future yield on related investments.

All of the Company's short-duration contracts are generated from our accident and health business, and are accounted for based on actuarial estimates of the amount of loss inherent in that period's claims, including losses incurred for which claims have not been reported. Short-duration contract loss estimates rely on actuarial observations of ultimate loss experience for similar historical events.

Liabilities for insurance reserves on certain short-term medical coverages, such as medical stop-loss, are computed using completion factors and expected loss ratios derived from actual historical premium and claim data. Reserves for medical stop-loss insurance are more volatile in nature than those for fully insured medical insurance. This is primarily due to the excess nature of medical stop-loss, with very high deductibles applying to specific claims on any individual claimant and in the aggregate for a given group. The level of these deductibles makes it more difficult to predict the amount and payment pattern of such claims. Furthermore, these excess claims are highly sensitive to changes in factors such as medical trend, provider contracts and medical treatment protocols, adding to the difficulty in predicting claim values and estimating reserves. Also, because medical stop-loss is in excess of an underlying benefit plan, there is an additional layer of cl aim reporting and processing that can affect claim payment patterns. Finally, changes in the distribution of business by effective month can affect reserve estimates due to the time required to accumulate claims against the stop-loss deductible, unlike fully insured medical.

Reserves for fully insured medical business are established to provide for the liability for incurred but not paid claims. Reserves are calculated using standard actuarial methods and practices. Historical paid claim patterns are reviewed and estimated development factors applied to immature incurred months to calculate these reserves.

While these calculations are based on standard methodologies, they are estimates based on historical patterns. To the extent that actual claim payment patterns differ from historical patterns, such estimated reserves may be redundant or inadequate. The effects of such deviations are evaluated by considering claim backlog statistics and reviewing the reasonableness of projected claim ratios. Other factors which may affect the accuracy of reserve estimates include the proportion of large claims which may take longer to adjudicate, changes in billing patterns by providers and changes in claim management practices such as hospital bill audits.

The Company's long term disability reserves are developed using actuarial principles and assumptions that consider, among other things, future offsets and recoveries, elimination periods, interest rates, probability of rehabilitation or mortality, incidence and termination rates based on the Company's experience. The loss reserve is made up of case reserves, incurred but not reported reserves, reopen reserves, and loss adjustment expense. Incurred but not reported and reopen reserves are calculated by a hind-sight study, which takes historical experience and develops the reserve as a percentage of premiums from prior years.

For traditional life insurance products, the Company computes insurance reserves primarily using the net premium method based on anticipated investment yield, mortality, ~~(morbidity on health insurance)~~ and withdrawals. ~~Liabilities for insurance reserves on certain short-term medical coverages were computed using completion factors and expected loss ratios derived from actual historical premium and claim data.~~ These methods are widely used in the life ~~and health~~ insurance industry to estimate the liabilities for insurance reserves. Inherent in these calculations are management and actuarial judgments and estimates ~~which~~that could significantly impact the ending reserve liabilities and, consequently, operating results. Actual results may differ, and these estimates are subject to interpretation and change.

Policyholder funds represent interest-bearing liabilities arising from the sale of products, such as universal life, interest-sensitive life and annuities. Policyholder funds are comprised primarily of deposits received and interest credited to the benefit of the policyholder less surrenders and withdrawals, mortality charges and administrative expenses.

Interest credited to policyholder funds represents interest accrued or paid on interest-sensitive life policies and investment policies. Amounts charged to operations (including interest credited and benefit claims incurred in excess of related policyholder account balances) are reported as insurance benefits, claims and reserves-life and annuity. Credit rates for certain annuities and interest-sensitive life policies are adjusted periodically by the Company to reflect current market conditions, subject to contractually guaranteed minimum rates.

Management believes that the Company's ~~method~~methods of estimating the liabilities for insurance reserves provided appropriate levels of reserves at ~~March 31,~~June 30, 2005 and December 31, 2004. Changes in the Company's ~~reserves~~reserve estimates are ~~reco rded~~recorded through a charge or credit to its earnings.

~~Premiums from short-duration~~Costs that vary with and are primarily related to acquiring insurance policies and investment type contracts are ~~recognized~~deferred and recorded as ~~revenue~~deferred policy acquisition costs ("DAC"). These costs are principally broker fees, agent commissions, and the purchase prices of acquired blocks of business. DAC is amortized to expense and reported separately in the Consolidated Statements of Operations.

For traditional life insurance and other premium-paying policies, amortization of DAC is recognized over the ~~period~~life of the ~~contracts~~business and charged to expense in proportion to premium revenues. Assumptions used in the ~~amount~~amortization of DAC are determined based upon the conditions as of the date of policy issue and are not generally revised during the life of the policy. Generally, the amortization period for these contracts approximates the estimated lives of the policies.

For investment type contracts such as annuities and interest-sensitive life business, amortization of DAC is based on the present value of the estimated gross profits ("EGPs"), which consists of margins of mortality, investment interest spreads, and other expected revenues and expenses. Adjustments are made every quarter to reflect actual gross margins experienced. Once a year, the Company reviews the underlying assumptions that produced the prospective EGP's on a best-estimate basis. Prospective unlocking occurs only when the Company determines that the current assumptions underlying the EGP's are no longer a best-estimate for the future. Factors of the best-estimate that may lead to prospective unlocking are changes in actual versus expected mortality, persistency, investment interest spreads, or other sources of the EGP.

For health insurance ~~protection provided. Premiums from long-duration contracts are~~policies, amortization of DAC is recognized ~~as revenue when due from policyholders.~~over the life of the business and charged to expense in proportion to premium revenues.

The Company accounts for its investments in debt and equity securities under Statement of Financial Accounting Standards No. 115 ("SFAS 115"),Accounting for Certain Investments in Debt and Equity Securities. The Company has classified all of its investments as available-for-sale or trading securities. These investments are carried at fair value based on quoted market prices with unrealized gains and losses reported in either accumulated other comprehensive income (loss) in the accompanying Consolidated Balance Sheets for available-for-sale securities or as unrealized gains or losses in the accompanying Consolidated Statements of Operations for trading securities. The Company has approximately $8.0 million and $7.5 million in trading accounts at June 30, 2005 and December 31, 2004, respectively. Net realized gains and losses on investments are computed using the specific identification method and are reported in the accompanying Consolidated Statements of Operations. Declines in value judged to be other-than-temporary are determined based on the specific identification method and are reported in the ~~accompanyi ng~~accompanying Consolidated Statements of Operations as net realized losses. The factors considered by management in determining when a decline is other than temporary include but are not limited to: the length of time and extent to which the fair value has been less than cost; the financial condition and near-term prospects of the issuer; adverse changes in ratings announced by one or more rating agencies; whether the issuer of a debt security has remained current on principal and interest payments; whether the decline in fair value appears to be issuer specific or, alternatively, a reflection of general market or industry conditions; and the Company's intent and ability to hold the security for a period of time sufficient to allow for a recovery in fair value. For securities within the scope of Emerging Issues Task Force Issue 99-20, such as purchased interest-only securities, an ~~impairment~~impa irment loss is recognized when there has been a decrease in expected cash flows combined with a decline in the security's fair value ~~b elow~~below cost.

Results of Operations for the Three Months Ended ~~March 31,~~June 30, 2005 Compared to the Three Months Ended ~~March 31,~~June 30, 2004

Net income was ~~$5.8~~$5.9 million, or ~~$.40~~$.41 per share, diluted, for the three months ended ~~March 31,~~June 30, 2005 compared to ~~$5.5~~$5.6 million, or ~~$.38~~$.39 per share, diluted, for the three months ended ~~March 31,~~June 30, 2004. The Company's income before taxes ~~increased $.6~~was $8.6 million ~~to $9.0 million~~ for both the three months ended ~~March 31,~~June 30, 2005 ~~from $8.4 million for~~and 2004. The Company had net realized and unrealized gains of ~~$.2~~$.8 million in the ~~first~~second quarter of 2005 compared to ~~$.9~~$.4 million in the second quarter of 2004. Income tax expense ~~increased~~decreased $.3 million to ~~$3.2~~$2.8 million in the ~~first~~second quarter of 2005, an effective rate of ~~36.1%~~32%, from ~~$2.9~~$3.1 million in 2004, an effective rate of ~~34.9%~~35%, primarily reflecting the increase in ~~income before taxes.~~tax advantaged securities in the portfolio. Information by business segment for the three months ended ~~March 31,~~June 30, 2005 and ~~March 31,~~ 2004 is as follows:

										Benefits,		Amortization		Selling,													Benefits,		Amortization		Selling,
				Net						Claims		of Deferred		General							Net				Fee and		Claims		of Deferred		General
		Premiums		Investment		Equity		Other		and		Acquisition		and					Premiums		Investment		Equity		Other		and		Acquisition		and
March 31, 2005		Earned		Income		Income		Income		Reserves		Costs		Administrative		Total
June 30, 2005																		June 30, 2005	Earned		Income		Income		Income		Reserves		Costs		Administrative		Total
(In thousands)	(In thousands)																	(In thousands)

Medical stop-loss	Medical stop-loss	$	25,136	1,385		477		4,249		16,026		-		5,935		$	9,286	Medical stop-loss	$	31,602	714		509		960		17,444		-		9,531		$	6,810
Strategic health	Strategic health	2,964		11		-		1,375		2,173		150		2,764		(737)		Strategic health	2,216		4		-		1,512		1,330		150		2,663		(411)
Group disability,	Group disability,																	Group disability,
	life annuities																	life, annuities
	and DBL	9,802		2,032		-		116		7, 855		36		3,641		418		and DBL	10,402		2,179		-		93		6,750		39		3,897		1,988
Individual life,	Individual life,																	Individual life,
	annuities																	annuities
	and other	6,426		5,592		-		186		8,400		1,317		1,536		951		and other	6,269		5,678		-		181		7,825		1,345		1,826		1,132
Credit life and	Credit life and																	Credit life and
	disability		5,100		219		-		45		2,207		1,148		1,777		232	disability		5,292		227		-		23		2,438		1,139		1,854		111
Corporate	Corporate		-		260		-		50		-		-		855		(545)	Corporate		-		235		-		50		-		-		1,257		(972)
Sub total	Sub total	$	49,428		9,499		477		6,021		36,661		2,651		16,508		9,605	Sub total	$	55,781		9,037		509		2,819		35,787		2,673		21,028		8,658
Realized and un-	Realized and un-																	Realized and un-
	realized gains															248		realized gains															836
Interest expense	Interest expense																(845)	Interest expense																(865)
Income before	Income before																	Income before
	income taxes															9,008		income taxes															8,629
Income taxes	Income taxes																3,256	Income taxes																2,763
Net income	Net income															$	5,752	Net income															$	5,866

										Benefits,		Amortization		Selling,													Benefits,		Amortization		Selling,
				Net						Claims		of Deferred		General							Net				Fee and		Claims		of Deferred		General
March 31, 2004		Premiums		Investment		Equity		Other		and		Acquisition		and
June 30, 2004																		June 30, 2004	Premiums		Investment		Equity		Other		and		Acquisition		and
(In thousands)	(In thousands)	Earned		Income		Income		Income		Reserves		Costs		Administrative		Total		(In thousands)	Earned		Income		Income		Income		Reserves		Costs		Administrative		Total

Medical stop-loss	Medical stop-loss	$	21,841	753		621		47		13,669		-		3,986		$	5,607	Medical stop-loss	$	25,347	427		525		464		15,771		-		6,034			4,958
Group disability,	Group disability,																	Group disability,
	life annuities																	life, annuities
	and DBL	9,309		1,996		-		132		7,077		31		3,659		670		and DBL	9,651		2,470		-		(3)		7,280		36		3,086		1,716
Individual life,	Individual life,																	Individual life,
	annuities and																	annuities and
	other	4,459		6,266		-		283		6,881		388		1,684		2,055		other	5,376		7,597		-		(156)		6,968		1,703		2,006		2,140
Credit life and	Credit life and																	Credit life and
	disability		4,728		233		-		11		2,304		960		1,761		(53)	disability		5,065		287		-		35		1,858		1,023		1,561		945
Corporate	Corporate		-		735		-		123		-		-		1,027		(169)	Corporate		-		502		-		101		-		-		1,694		(1,091)
Sub total	Sub total	$	40,337		9,983		621		596		29,931		1,379		12,117		8,110	Sub total	$	45,439		11,283		525		441		31,877		2,762		14,381		8,668
Realized and un-	Realized and un-																	Realized and un-
	realized gains															895		realized gains															425
Interest expense	Interest expense																(560)	Interest expense																(502)
Income before	Income before																	Income before
	income taxes																8,445	income taxes																8,591
Income taxes	Income taxes																2,945	Income taxes																3,041
Net income	Net income															$	5,500	Net income															$	5,550

Total premiums earned grew ~~$9.1~~$10.3 million to ~~$49.4~~$55.8 million in 2005 from ~~$40.3~~$45.5 million in 2004. The increase is due to: (i) the Medical Stop-Loss segment which increased ~~$3.3~~$6.3 million due to ~~$2.9~~$5.8 million from increased retentions and ~~$.4~~$.5 million in premiums earned on an aggregate excess of loss retrocession reinsurance agreement ("Excess of Loss Agreement"), effective as of January 1, 2005, with a reinsurer for the prospective portion of its 2004 treaty year business; ~~partially offset by a decrease from HMO Reinsurance;~~ (ii) the new Strategic Health segment which had ~~$3.0~~$2.2 million of premiums in the ~~first~~second quarter of 2005; (iii) the ~~Group~~Individual and Other segment which increased $.5 million due to increased retention in GTL, and new business in Group A&H; partially offset by the 20% coinsurance agreement with Independence American entered into in July of 2004 on the DBL line; (iv) the individual and other segment which increased $2.0$.9 million primarily from an increase in ~~VFD due to increased writi ngs~~blanket accident and sickness policy premium, policy acquisitions of Ordinary Life ~~lines primarily due to~~blocks and growth in the military and civilian government employee division; (iv) an increase of $.7 million in the group segment due to an increase in retentions in group life and new business in group A&H, partially offset by a dec rease in DBL due to the 20% reinsurance agreement with Independence American effective July 1, 2004; and (v) a ~~$.3~~$.2 million increase in the credit life and disability ~~segment.~~segment due to new business.

The Company experienced ~~a decrease~~an increase in realized and unrealized gains of ~~$.6~~$.4 million. Decisions to sell securities are based on cash flow needs, investment opportunities and economic and market conditions, thus creating fluctuations in gains and losses from period to period.

Total net investment income decreased ~~$.5~~$2.2 million primarily due to a move toward higher grade securities which provide lower yields and municipal securities which also provide lower yields, but ~~will~~ result in income tax advantaged earnings. In addition, the Company maintained a higher level of liquid assets which yield a lesser return. The annualized return on investments was ~~5.1%~~4.9% in the ~~first~~second quarter of 2005 versus ~~6.1%~~6.7% in the ~~first~~second quarter of 2004.

Equity income from AMIC was comparable to the second quarter of 2004, as lower income earned by AMIC was offset by an increase in IHC's ownership to 42% in the second quarter of 2005 from 40% a year ago.

MGU fee income increased $1.7 million due to the acquisitions of both Majestic and Health Plan Administrators ("HPA") in July 2004 and January 2005, respectively.

Total other income increased $.7 million primarily generated by the Stop-Loss line business.

Benefits, claims and reserves increased $3.9 million. The increase is due to: (i) $1.7 million in the Medical Stop-Loss segment resulting from an increase in retention partially offset by a decrease in loss ratios in 2005 as compared to the prior year; (ii) an increase of $1.3 million in the Strategic Health segment for which there were no comparable results in 2004; (iii) a $.8 million increase in the individual and other segment due to higher losses on the assumed block of annuity and life business in run-off status, and higher losses on the ordinary life line due to the acquisition and (iv) an increase of $.6 million in the credit line due to increased premiums and high loss ratios. These increases were partially offset by a $.5 million decrease in the Group segment due to the previously mentioned DBL reinsurance agreement, partially offset by an increase in retentions in the Group Life line.

Interest expense increased $.4 million primarily due to the issuance of $15.5 million of fixed rate junior subordinated debt during the fourth quarter of 2004. The Company has $38.2 million of fixed rate debt (including $25.7 million of junior subordinated debt) and $12.4 million of floating rate junior subordinated debt. The floating rate debt carried an interest rate of 7.0% in 2005 as compared to 5.0% in 2004.

Total selling, general and administrative expenses increased $6.6 million in the second quarter of 2005 as compared to the second quarter of 2004. The increase is primarily due to (i) $2.7 million in expenses from subsidiaries acquired after the second quarter of 2004, including expenses associated with the commencement of the Strategic Health segment; (ii) a $3.5 million increase in commissions and other general expenses in the Medical Stop-Loss segment due to a higher level of premiums earned; and (iii) $.4 million in other general expenses.

Results of Operations for the Six Months Ended June 30, 2005 Compared to the Six Months Ended June 30, 2004

Net income was $11.6 million, or $.82 per share, diluted, for the six months ended June 30, 2005 compared to $11.1 million, or $.77 per share, diluted, for the six months ended June 30, 2004. The Company's income before taxes increased $.6 million to $17.6 million for the six months ended June 30, 2005 from $17.0 million for the first six months of 2004. The Company had net realized and unrealized gains of $1.1 million in the first six months of 2005 compared to $1.3 million in the first six months of 2004. Income tax expense remained substantially unchanged at $6.0 million, an effective rate of 34% for the six months ended June 30, 2005, and an effective rate of 35% for the six months ended June 30, 2004, primarily reflecting the increase in tax advantaged securities in the portfolio. Information by business segment for the six months ended June 30, 2005 and 2004 is as follows:

Total premiums earned grew $19.4 million to $105.2 million in 2005 from $85.8 million in 2004. The increase is due to: (i) the Medical Stop-Loss segment which increased $9.5 million due to $9.3 million of increased retentions and $.8 million in premiums earned on the previously mentioned Excess of Loss Agreement, partially offset by decreased premium of $.6 million from HMO Reinsurance and Provider Excess; (ii) the new Strategic Health segment which had $5.2 million of premiums in the first half of 2005; (iii) the Individual and Other segment which increased $2.8 million comprised of an increase in retention in blanket accident and sickness policies, an increase in the Ordinary Life line primarily due to acquisitions and growth in the military and civilian government employee division; (iv) the Credit segment which increased $.6 million; and (v) a $1.3 million increase in the group line due to a $3.0 million increase in group LTD and group life, partially offset by a $1.7 mill ion decrease in DBL due to the 20% reinsurance agreement with Independence American as of July 1, 2004.

The Company experienced a decrease in realized and unrealized gains of $.2 million. Decisions to sell securities are based on cash flow needs, investment opportunities and economic and market conditions, thus creating fluctuations in gains and losses from period to period.

Total net investment income decreased $2.7 million primarily due to a move toward higher grade securities which provide lower yields and municipal securities which also provide lower yields, but result in income tax advantaged earnings. In addition, the Company maintained a higher level of liquid assets which yield a lesser return. The annualized return on investments was 5.0% for the six months ended June 30, 2005 versus 6.4% for the comparable period of 2004.

Equity income from AMIC decreased $.2 million due to a decrease in earnings of AMIC, partially offset by an increase in IHC's ownership to 42% at June 30, 2005.

MGU fee income increased $3.9 million due to the acquisitions of Majestic and HPA in July 2004 and January 2005, respectively.

Total other income increased ~~$5.4~~$3.9 million due primarily to (i) a $2.1 million increase from a commutation agreement, pursuant to which, effective as of January 1, 2005, the reinsurer will return 94% of the net premium collected to date with respect to the 2003 Medical Stop-Loss business ceded to such reinsurer, and the Company will release most future liabilities of such reinsurer with respect to such business; (ii) a $1.4 million increase from the Excess of Loss Agreement related to the expired portion of the 2004 treaty year ~~business,~~business; and (iii) ~~a $1.9~~$.4 million ~~increase in fee income due to~~generated primarily from the ~~acquisitions of Majestic and HPA in July 2004 and January 2005, respectively.~~Stop-Loss business.

Benefits, claims and reserves increased ~~$6.7~~$10.6 million. The increase is due to: (i) ~~$2.3~~$4.0 million in the Medical Stop-Loss segment primarily resulting from an increase in retention ~~and an increase~~ in ~~loss reserves in 2005 as compared to 2004;~~2005; (ii) an increase of ~~$2.2~~$3.5 million in the Strategic Health segment ~~for~~ which ~~there were no comparable results in~~was not formed until after the third quarter of 2004; (iii) an increase of $.8 million in the Group segment due to increased claims experience in the GTL and LTD lines and increased business in the Group A&H lines; partially offset by the 20% DBL coinsurance agreement previously mentioned; and (iv) a ~~$1.5~~$2.4 million increase in the individual and other segment due to higher losses on the assumed block of annuity and life business in run-off status, and ~~higher~~ losses on the ordinary life line due to ~~acquisitions. These increases were partially offset by~~acquisitions; (iv) a ~~$.1~~$.5 million ~~decrease~~increase in credit claims and ~~reserves.~~reserves due to the increase in premiums; and (v) an increase of $.2 million in the Group segment due to increased claims experience in the GTL line, and increased business in the Group A&H lines, partially offset by lower loss ratios in the LTD line and lower reserves in the DBL line due to the 20% coinsurance agreement previously mentioned.

Amortization of deferred acquisition costs increased ~~$1.3~~$1.2 million due to amortization of expenses related to ~~acquisitions,~~ the ~~addition of the~~new Strategic Health business and ~~increased production in the military line.~~acquisitions of policy blocks.

Interest expense increased ~~$.3~~$.6 million primarily due ~~primarily~~ to the issuance of $15.5 million of ~~junior~~fixed rate subordinated debt during the fourth quarter of 2004. The Company has $12.4 million of floating rate junior subordinated debt which carried an interest rate of 6.7% in 2005 as compared to 5.1% in 2004.

~~Total selling,~~Selling, general and administrative expenses increased ~~$4.4~~$11.0 million ~~in the first quarter of 2005 as compared to the first quarter of 2004. The increase is primarily~~ due to (i) ~~$2.8~~$5.4 million in commissions and other general expenses in the Medical Stop-Loss line of ~~expenses from subsidiaries acquired after~~business which corresponds with the ~~first quarter of 2004, including~~increase in premiums; (ii) $5.4 million in consulting and general expenses associated with the ~~commencement of the Strategic Health segment; (ii) a $1.7 million increase in commissions due to a higher level of premiums earned;~~HPA and Majestic acquisitions; and (iii) ~~higher audit fees for compliance with the Sarbanes-Oxley Act of 2002. These higher costs were partially offset by a reduction of~~$.2 million in other expenses.

The Insurance Group normally provides cash flow from: (i) operations; (ii) the receipt of scheduled principal payments on its portfolio of fixed income securities; and (iii) earnings on investments. Such cash flow is partially used to finance liabilities for insurance policy benefits. These liabilities represent long-term and short-term obligations which are calculated using certain assumed interest rates.

The nature and quality of insurance company investments must comply with all applicable statutes and regulations, which have been promulgated primarily for the protection of policyholders. Of the aggregate carrying value of the Insurance Group's investment assets, approximately ~~94.5%~~90.0% was invested in investment grade fixed income securities, resale agreements, policy loans and cash and cash equivalents at ~~March 31,~~June 30, 2005. Also at such date, approximately ~~99.2%~~96.5% of the Insurance Group's fixed maturities were investment grade. These investments carry less risk and, therefore, lower interest rates than other types of fixed maturity investments. At ~~March 31,~~June 30, 2005, approximately ~~.8%~~3.5% of the carrying value of fixed maturities was invested in diversified non-investment grade fixed income securities (investments in such securities have different risks than investment grade securities, including greater risk of loss upon default, and thinner trading markets). The Company does not have any mortgage loans or non-performing fixed maturities at ~~March 31,~~June 30, 2005.

The Company reviews its investments regularly and monitors its investments continually for impairments. For the ~~three~~six months ended ~~March 31,~~June 30, 2005, the Company did not record any losses for other than temporary impairments. For the ~~three~~six months ended ~~March 31,~~June 30, 2004, the Company recorded a realized loss for other than temporary impairments of ~~$.6~~$0.6 million onrelated to certain interest only securities ("IO Securities") resulting from expected ~~prepayments~~prepayment of the mortgage obligations underlying the IO Securities due to falling interest rates. At ~~March 31,~~June 30, 2005, the Company had a negligible amount invested in IO Securities.

The Company's gross unrealized losses on fixed maturities totaled ~~$16.1~~$7.0 million at ~~March 31,~~June 30, 2005. Substantially all of these securities were investment grade. The unrealized losses have been evaluated in accordance with the Company's policy and were determined to be temporary in nature at ~~March 31,~~June 30, 2005. The Company holds all fixed maturities as available-for-sale securities and, accordingly, marks all of its fixed maturities to market through accumulated other comprehensive income or loss.

Total investments ~~decreased $19.4~~increased $93.8 million to ~~$702.7~~$816.0 million at ~~March 31,~~June 30, 2005. The ~~decrease~~increase is primarily due to the ~~utilization~~investment of the cash ~~for the~~received in an acquisition of ~~Health Plan Administrators, Inc. in January~~a block of life and annuity policies effective June 9, 2005. Total stockholders' equity ~~decreased $2.1~~increased $10.3 million to ~~$186.8~~$199.2 million at ~~March 31,~~June 30, 2005, primarily due to an$11.6 million in net income for the six months ended June 30, 2005 and a $3.1 million increase in net unrealized ~~losses~~gains on fixed maturity investments, ~~and~~partially offset by net repurchases of the Company's common ~~stock partially offset by net income for the three months ended March 31, 2005.~~stock.

The Company had net receivables from reinsurers of ~~$113.7~~$109.6 million at ~~March 31,~~June 30, 2005. Substantially all of the business ceded to such reinsurers is of short duration. All of these receivables are either due either from its affiliate, Independence American Insurance Company, highly rated companies or are adequately secured. Accordingly, no allowance for doubtful accounts was necessary at ~~March 31,~~June 30, 2005. As of ~~March 31,~~June 30, 2005, the balance due from Independence American was ~~$16.1~~$13.8 million.

Corporate derives its funds principally from: (i) dividends and interest income from the Insurance Group; (ii) management fees from its subsidiaries; and (iii) investment income from Corporate liquidity. Regulatory constraints historically have not affected the Company's consolidated liquidity, although state insurance laws have provisions relating to the ability of the parent company to use cash generated by the Insurance Group.

Total Corporate liquidity (cash, cash equivalents, resale agreements, short-term investments, marketable securities and partnership interests) amounted to ~~$34.5~~$30.0 million at ~~March 31,~~June 30, 2005.

Due to its strong capital ratios, broad licensing and excellent asset quality and credit-worthiness, the Insurance Group remains well positioned to increase or diversify its current activities. It is anticipated that future acquisitions or other expansion of operations will be funded internally from existing capital and surplus and parent company liquidity. In the event additional funds are required, it is expected that they would be borrowed or raised in the public or private capital markets to the extent determined to be necessary or desirable.

In accordance with SFAS No. 115, the Company may carry its portfolio of fixed income securities either as ~~held to maturity~~held-to-maturity (carried at amortized cost), as trading securities (carried at fair market value) or as available-for-sale (carried at fair market value). The Company has chosen to carry all of its debt securities as available-for-sale. The Company experienced a ~~$5.3~~$3.1 million increase in unrealized ~~losses~~gains on securities available-for-sale, net of deferred taxes and deferred policy acquisition costs, in accumulated other comprehensive ~~loss,~~income (loss), reflecting net unrealized ~~losses~~gains of ~~$7.3~~$1.1 million at ~~March 31,~~June 30, 2005 compared to net unrealized losses of $2.0 million at December 31, 2004. From time to time, as warranted, the Company employs investment strategies to mitigate interest rate and other market exposures. However, the portfolio will always have interest rate exposure given the matching of its liabilities, and therefore portfolio valuations will fluctuate with market interest ~~rates.~~rate s.

The Company's contractual obligations and their expected maturities at ~~March 31,~~June 30, 2005 are not materially different from the schedule of such obligations at December 31, 2004 which was included in Item 7 of the Company's Annual Report on Form 10-K.

IHC has a program, initiated in 1991, under which it repurchases shares of its common stock. In June 2004, the Board of Directors authorized an additional 450,000 shares to be repurchased under the 1991 plan. As of ~~March 31,~~June 30, 2005, ~~275,637~~159,837 shares were still authorized to be repurchased under the plan.

2005	2005				Maximum Number	2005				Maximum Number
		Number of		Average Price	of Shares Which		Number of		Average Price	of Shares Which
Month of		Shares		of Repurchased	Can be		Shares		of Repurchased	Can be
Repurchase		Repurchased		Shares	Repurchased		Repurchased		Shares	Repurchased

January		100,000	$	18.54	320,037		100,000	$	18.54	320,037
February		-		-	320,037		-		-	320,037
March		44,400		18.07	275,637		44,400		18.07	275,637
April							53,600		18.10	222,037
May							46,000		18,10	176,037
June							16,200		17.60	159,837

The Company continues to anticipate favorable operating performance in 2005. During the first six months of this year, IHC advanced its new strategic health initiatives, appointed a new Medical Stop-Loss MGU to increase distribution while implementing stricter underwriting guidelines in order to improve profitability, and completed a significant block acquisition.

Standard Life has received approval to assume, as of January 1, 2005, a $50 million block of employer-sponsored group major medical business, and is currently awaiting approval of the assumption certificates in certain states. IHC has already begun distributing this product in several states through distribution sources including CA Services, in which the Company has an equity interest. Ultimately, IHC anticipates marketing this product in 36 states. As a result of its acquisition of Health Plan Administrators ("HPA"), IHC has begun writing short-term medical in 36 states, and hopes to have this product approved in 46 states by January 2006. In addition to HPA's distribution sources, some of the Company's Medical Stop-Loss MGUs will market this product through their distribution channels. As a consequence of its acquisition of GroupLink, Inc. the Company will significantly enlarge its dental and vision business through the filing of new products in 43 states. Previously, dental and vision was only written as a rider to a health insurance policy. Finally, IHC will begin filing a limited medical policy in selected states, which the Company expects to begin marketing in the first quarter of 2006.

With respect to its core business of Medical Stop-Loss, the Company has experienced a decrease in gross premiums due to its tightened underwriting guidelines, but has increased net premiums due to its increased retention percentage. The Company increased its average retention on Medical Stop-Loss written by Standard Life and Madison Life from 30% to 34% from 2003 to 2004 and to 41% and 46.3% for the six months and three months ended June 30, 2005, respectively. In 2004, approximately 71% of the Company's Medical Stop-Loss business was underwritten by MGUs in which the Company or its affiliates have significant equity interests. The Company anticipates that these MGUs will continue to contribute a high percentage of the Insurance Group's premiums in the Medical Stop-Loss line of business in 2005. IHC appointed a new MGU, which is expected to partially offset the decrease in gross written premiums. The Medical Stop-Loss market is generally cyclical in nature. When a product experiences sever al consecutive years of underwriting profitability, it is not unusual for there to be more competitors entering that line which can increase pressure on pricing and create a "softer" market. The Medical Stop-Loss market began to "soften" in 2003, and less favorable conditions continued through 2004 and has remained "soft" in 2005. Despite these market conditions, the Company produced profitable results in 2003 and 2004, and expects continued profitability in 2005. As a result of these market conditions, the rate IHC is able to charge for Medical Stop-Loss increased at a lesser rate in recent years, however, increases in medical trend have also been held in check to a greater extent and deductibles and attachment points have increased. This reduces IHC's overall risk exposure. The Company remains optimistic that it will continue to produce profitable results, however, its ability to grow the Medical Stop-Loss line in the balance of 2005 may be somewhat limited. IHC's new lines of business (major medical, shor t-term medical, dental and vision) are less volatile than Medical Stop-Loss. The Company is optimistic that these lines will yield profitable results while producing significant growth.

The Company's acquisitions group closed its most significant transaction since 1999 with the acquisition of a block of life insurance policies with approximately $120 million of reserves, consisting of approximately $77 million of traditional life reserves, approximately $40 million of universal life and interest sensitive life reserves and approximately $3 million of other reserves. Madison National Life will be adding about 50,000 new policyholders with this acquisition.

The Company manages interest rate risk by seeking to maintain a portfolio with a duration and average life that falls within the band of the duration and average life of the applicable liabilities. Options may be utilized to modify the duration and average life of such assets.

The Company monitors its investment portfolio on a continuous basis and believes that the liquidity of the Insurance Group will not be adversely affected by its current investments. This monitoring includes the maintenance of an asset-liability model that matches current insurance liability cash flows with current investment cash flows.

The expected change in fair value as a percentage of the Company's fixed income portfolio at ~~March 31,~~June 30, 2005 given a 100 to 200 basis point rise or decline in interest rates is not materially different than the expected change at December 31, 2004 included in Item 7 of the Company's Annual Report on Form 10-K. In the Company's analysis of the asset-liability model, a 100 to 200 basis point change in interest rates on the Insurance Group's liabilities would not be expected to have a material adverse effect on the Company. With respect to its liabilities, if interest rates were to increase, the risk to the Company is that policies would be surrendered and assets would need to be sold. This is not a material exposure to the Company since a large portion of the Insurance Group's interest sensitive policies are burial policies that are not subject to the typical surrender patterns of other interest sensitive policies, and many of the Insurance Group's universal life and annuity policies were ~~iss ued~~issu ed by liquidated companies and therefore tend to exhibit lower surrender rates than such policies of continuing companies. Additionally, there are charges to help offset the benefits being surrendered. If interest rates were to decrease substantially, the risk to the Company is that some of its investment assets would be subject to early redemption. This is not a material exposure because the Company would have additional gains in its portfolio to help offset the future reduction of investment income. With respect to its investments, the Company employs (from time to time as warranted) investment strategies to mitigate interest rate and other market exposures.

The President and the Chief Financial Officer of the Company (its principal executive officer and its principal financial officer, respectively) have concluded, based on their evaluation as of the end of the period covered by this Report, that the Company's disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in the reports filed or submitted by it under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and include controls and procedures designed to ensure that information required to be disclosed by the Company in such reports is accumulated and communicated to the Company's management, including the President and the Chief Financial Officer, as appropriate, and allow timely decisions regarding required disclosure.

There have not been any changes in the Company's internal control over financial reporting during the fiscal quarter ended ~~March 31,~~June 30, 2005 that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

The Company is involved in legal proceedings and claims which arise in the ordinary course of its businesses. The Company has established reserves that it believes are sufficient given information presently available related to its outstanding legal proceedings and claims. The Company believes the results of the other pending legal proceedings and claims are not expected to have a material adverse effect on its ~~results of operations,~~ financial condition or cash ~~flows.~~flows, although there could be such an effect on its results of operations for a particular period.

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Delaware		58-1407235
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

Class	Outstanding at ~~May 9,~~August 8, 2005
Common stock, $ 1.00 par value	~~13,912,157~~13,898,777 Shares

PART I - FINANCIAL INFORMATION				PAGE
					NO.

		Item 1. Financial Statements

			Consolidated Balance Sheets -
			~~March 31,~~June 30, 2005 (unaudited) and December 31, 2004	3

			Consolidated Statements of Operations -
			Three Months and Six Months Ended ~~March 31,~~June 30, 2005 and 2004 (unaudited)	4

			Consolidated Statements of Cash Flows -
			~~Three~~Six Months Ended ~~March 31,~~June 30, 2005 and 2004 (unaudited)	5

			Notes to Consolidated Financial Statements (unaudited)	6

		Item 2. Management's Discussion and Analysis of Financial Condition		1314
			and Results of Operations

		Item 3. Quantitative and Qualitative Disclosures about Market Risk		2129

		Item 4. Controls and Procedures		2230

PART II - OTHER INFORMATION

		Item 1. Legal Proceedings		2230

		Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		2230

		Item 3. Defaults Upon Senior Securities		2231

		Item 4. Submission of Matters to a Vote of Security Holders		2231

		Item 5. Other Information		2231

		Item 6. Exhibits		2331

	Signatures			2432

				2005			2004
			(In thousands)

Liabilities:
	Insurance reserves - life	$	76,791		$	-
	Funds on deposit		40,419			26,585
	Other policyholders' funds		2,573			-
	Other		224			-

			120,007			26,585

Non-cash assets:
	Other investments (policy loans)		10,539			-
	Deferred acquisition costs		14,183			800
	Due and unpaid premiums		2,158			-
	Due from reinsurers		3,844			-
			30,724			800
Cash received		$	89,283		$	25,785